Few data exist on the medicoeconomic usefulness of PET in the management of
metachronous liver metastases from colorectal cancer. This study was designed to assess …

With the increasing possibilities for surgical treatment of colorectal liver metastases, careful
selection of patients who may benefit from surgical treatment becomes critical. The addition …

Background The role of 18-fluorodeoxyglucose positron emission tomography CT (18 FDG
PET/CT), as a prognostic factor for survival in colorectal cancer patients with liver …

Objective [F-18]-Fluorodeoxyglucose-positron emission tomography (FDG-PET) is used
increasingly in the work-up to surgery for patients with potentially resectable colorectal liver …

Background: 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) is
recognized as a powerful tool in the management of patients with recurrent and/or metastatic …

OBJECTIVES: Surgical resection and radio-frequency ablation (RFA) are standard
therapeutic procedures for colorectal metastases confined to the liver. The presence of …

Purpose The first aim of the review (aim 1) was to obtain the diagnostic performance values
of 18 F-FDG PET for the detection and staging of liver metastases in patients with colorectal …

3520 Background: Advances in chemotherapy and surgery have increased the number of
colorectal cancer patients eligible for hepatic resection. Detection of extrahepatic …

Introduction Surgical resection remains the only potentially curative treatment for colorectal
liver metastases (CLM). However, involvement of both the hepatic lobes or extrahepatic …

Background Positron emission tomography (PET), alone or combined with computed
tomography (CT), potentially enhances detection of occult metastatic colorectal cancer …